Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy
- PMID: 19850684
- PMCID: PMC2775644
- DOI: 10.1210/jc.2009-1340
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy
Abstract
Context: Different menopausal hormone therapies may have varied effects on specific cognitive functions. We previously reported that conjugated equine estrogens (CEE) with medroxyprogesterone acetate had a negative impact on verbal memory but tended to impact figural memory positively over time in older postmenopausal women.
Objective: The objective of the study was to determine the effects of unopposed CEE on changes in domain-specific cognitive function and affect in older postmenopausal women with prior hysterectomy.
Design: This was a randomized, double blind, placebo-controlled clinical trial.
Setting: The study was conducted at 14 of 40 Women's Health Initiative (WHI) clinical centers.
Participants: Participants were 886 postmenopausal women with prior hysterectomy, aged 65 yr and older (mean 74 yr), free of probable dementia, and enrolled in the WHI and WHI Memory Study (WHIMS) CEE-Alone trial for a mean of 3 yr and followed up for a mean of 2.70 yr.
Intervention: Intervention was 0.625 mg of CEE daily or placebo.
Main outcome measures: Annual rates of change in specific cognitive functions and affect, adjusted for time since randomization, were measured.
Results: Compared with placebo, unopposed CEE was associated with lower spatial rotational ability (P < 0.01) at initial assessment (after 3 yr of treatment), a difference that diminished over 2.7 yr of continued treatment. CEE did not significantly influence change in other cognitive functions and affect.
Conclusions: CEE did not improve cognitive functioning in postmenopausal women with prior hysterectomy. CEE was associated with lower spatial rotational performance after an average of 3 yr of treatment. Overall, CEE does not appear to have enduring effects on rates of domain-specific cognitive change in older postmenopausal women.
Figures
References
-
- Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651–2662 - PubMed
-
- Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH 2004 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291:2947–2958 - PubMed
-
- Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D 2003 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663–2672 - PubMed
-
- Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J 2004 Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291:2959–2968 - PubMed
-
- Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA 2004 The Women’s Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clinical Trials 1:440–450 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 32105-6/PHS HHS/United States
- N01-AG-9-2115/AG/NIA NIH HHS/United States
- 32100-2/PHS HHS/United States
- 24152/PHS HHS/United States
- 42129-32/PHS HHS/United States
- ZIA AG000190/ImNIH/Intramural NIH HHS/United States
- 32118-32119/PHS HHS/United States
- 32108-9/PHS HHS/United States
- 32122/PHS HHS/United States
- 44221/PHS HHS/United States
- 32111-13/PHS HHS/United States
- 42107-26/PHS HHS/United States
- 32115/PHS HHS/United States
- N01 WH022110/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical